title: Reply: To PMID 23719402.
authors: *Department of Ophthalmology, University of Lausanne, Switzerland †Inserm UMR1138, Physiopathology of Ocular Diseases: Therapeutic Innovations, Paris, France ‡Department of Ophthalmology, Hôtel-Dieu de Paris Hospital, France.
authors: Francine
authors: F
authors: Behar-Cohen
authors: Elodie
authors: E
authors: Bousquet
mesh_terms: D056833:Central Serous Chorioretinopathy / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use*; D013148:Spironolactone / Q000031:analogs & derivatives*
chemical_list: D000451:Mineralocorticoid Receptor Antagonists; D013148:Spironolactone